Stable benefit of embryonic stem cell therapy in myocardial infarction
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Conventional therapies for myocardial infarction attenuate disease progression without contributing significantly to repair. Because of the capacity for de novo cardiogenesis, embryonic stem cells are considered a potential source for myocardial regeneration, yet limited information is available on their ultimate therapeutic value. We treated infarcted rat hearts with CGR8 embryonic stem cells preexamined for cardiogenicity, serially probed left ventricular function, and determined final pathological outcome. Stem cell delivery generated new cardiomyocytes of embryonic stem cell origin that integrated with host myocardium within infarct regions. This resulted in a functional benefit within 3 wk that remained sustained over 12 wk of continuous follow-up and included a vigorous inotropic response to beta-adrenergic challenge. Integration of stem cell-derived cardiomyocytes was associated with normalized ventricular architecture, little scar, and a decrease in signs of myocardial necrosis. In contrast, sham-treated infarcted hearts exhibited ventricular cavity dilation and aneurysm formation, poor ventricular function, and a lack of response to beta-adrenergic stimulation. No evidence of graft rejection, ectopy, sudden cardiac death, or tumor formation was observed after therapy. These findings indicate that embryonic stem cells, through differentiation within the host myocardium, can contribute to a stable beneficial outcome on contractile function and ventricular remodeling in the infarcted heart.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
He, J.-Q., Ma, Y., Lee, Y., Thomson, J. A., & Kamp, T. J. (2003) · Circulation Research · doi:10.1161/01.res.0000080317.92718.99 · Cited by 800 · cited 1×
“Indeed, in vitro differentiation of embryonic stem cells produces cells that recapitulate the cardiac phenotype expressing characteristic cardiac markers and demonstrating functional excitation-contraction coupling (6, 13, 24, 32, 34).”
Background
Cited by
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction
Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., Ishino, K., Ishida, H., Shimizu, T., Kangawa, K., et al. (2006) · Nature Medicine · doi:10.1038/nm1391 · Cited by 1,193
Laflamme, M. A., & Murry, C. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1117 · Cited by 964
Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A. I., Ware, C. B., Masino, A., Muskheli, V., Pabon, L., Reinecke, H., & Murry, C. E. (2007) · The FASEB Journal · doi:10.1096/fj.06-6769com · Cited by 646
Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells
Chung, S., Dzeja, P. P., Faustino, R. S., Perez-Terzic, C., Behfar, A., & Terzic, A. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0766 · Cited by 509
Self-citationCao, F., Lin, S., Xie, X., Ray, P., Patel, M., Zhang, X., Drukker, M., Dylla, S. J., Connolly, A. J., Chen, X., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.588954 · Cited by 493
“fication of cell number; (4) no dilution with cell proliferation;”
BackgroundRepair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells
Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., & Terzic, A. (2009) · Circulation · doi:10.1161/circulationaha.109.865154 · Cited by 471
Self-citationZhang, M., Mal, N., Kiedrowski, M., Chacko, M., Askari, A. T., Popovic, Z. B., Koc, O. N., & Penn, M. S. (2007) · The FASEB Journal · doi:10.1096/fj.06-6558com · Cited by 457
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
Leri, A., Kajstura, J., & Anversa, P. (2005) · Physiological Reviews · doi:10.1152/physrev.00013.2005 · Cited by 451
Murry, C. E., Reinecke, H., & Pabon, L. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.002 · Cited by 360
Ménard, C., Hagège, A. A., Agbulut, O., Barro, M., Morichetti, M. C., Brasselet, C., Bel, A., Messas, E., Bissery, A., Bruneval, P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67380-1 · Cited by 290
Self-citationEschenhagen, T., & Zimmermann, W. H. (2005) · Circulation Research · doi:10.1161/01.res.0000196562.73231.7d · Cited by 261
Wang, L. L., Liu, Y., Chung, J. J., Wang, T., Gaffey, A. C., Lu, M., Cavanaugh, C. A., Zhou, S., Kanade, R., Atluri, P., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0157-y · Cited by 239
Fernandes, S., Naumova, A. V., Zhu, W. Z., Laflamme, M. A., Gold, J., & Murry, C. E. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.008 · Cited by 168
“In addition, mouse ESC-derived cardiomyocytes have been demonstrated to improve heart function when injected several weeks after myocardial injury [25], suggesting the feasibility of ESC-derived cardiomyocytes therapy for heart failure.”
BackgroundCell-Based Therapy for Myocardial Ischemia and Infarction: Pathophysiological Mechanisms
Laflamme, M. A., Zbinden, S., Epstein, S. E., & Murry, C. E. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092038 · Cited by 164
Metadata
- Authors
- Hodgson, D. M., Behfar, A., Zingman, L. V., Kane, G. C., Perez-Terzic, C., Alekseev, A. E., Pucéat, M., & Terzic, A.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2004-08
- Volume
- 287
- Issue
- 2
- Pages
- H471-H479
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2097328801
- Cited by
- 243
- References
- 1
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.